Ticker name:CTORCITIUS ONCOLOGY, INC.

Country: US-Sector: Healthcare, Industry: Drug Manufacturers - General

Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.

Market Cap 51M

Last close 0.547$

Key metrics

Largest 18 companies In Drug Manufacturers - General

# PositionTickerCompany NameMarket CapLast PriceAction
1LLYELI LILLY & Co1.3T1417.99$
2JNJJOHNSON & JOHNSON665B276.32$
3ABBVAbbVie Inc.521B294.83$
4MRKMerck & Co., Inc.371B150.36$
5NVSNOVARTIS AG315B164.98$
6AZNASTRAZENECA PLC293B189.01$
7AMGNAMGEN INC259B478.48$
8GILDGILEAD SCIENCES, INC.216B174.48$
9PFEPFIZER INC175B30.79$
10BMYBRISTOL MYERS SQUIBB CO131B64.19$
11SNYSanofi116B47.47$
12BIIBBIOGEN INC.38B254.46$
13ZTSZoetis Inc.37B89.2$
14OGNOrganon & Co.3.6B13.83$
15CTORCITIUS ONCOLOGY, INC.51M0.547$
16MIRAMIRA PHARMACEUTICALS, INC.24M0.561$
17SRXHSRX Global Inc.18M0.8871$
18SCLXScilex Holding Co16M1.83$